ProPhase Labs Inc
Diagnostics & Research
Healthcare
PRPH
18.06 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
4.50
52 week high
10.67
high
4.70
52 week low
4.23
previous Close
4.52
P/E ratio
market cap
106 M
div yield
0
net incoming
-3.44 M
-725.45 %
net profit margin
-26.03 %
-28.00 %
operating incoming
-4.66 M
-632.34 %
net change in cash
-5.79 M
-1.00 %
cash on hand
3.82 M
-60.22 %
cost of revenue
6.77 M
-22.93 %
top